Medicine and Dentistry
Advanced Cancer
14%
Alternative RNA Splicing
14%
Cancer
28%
Carcinogenesis
14%
Carcinoma
14%
Cell Surface
14%
Cervical Cancer
14%
Endometrial Cancer
14%
Endometrium Carcinoma
28%
Enzyme Linked Immunosorbent Assay
14%
Fas Ligand
14%
Female
28%
Krukenberg Tumor
42%
Malignant Neoplasm
14%
Natural Killer Cell
14%
Patient
57%
Prognostic Factor
14%
Programmed Cell Death
28%
Proportional Hazards Model
14%
Radiation Therapy
14%
Serum
100%
Serum Group
14%
Survival
28%
Survival Rate
14%
Uterine Cervix Carcinoma
28%
Nursing and Health Professions
Advanced Cancer
14%
Carcinogenesis
14%
Carcinoma
14%
Chemotherapy
14%
Control
28%
Death
14%
Donor
28%
Endometrium Cancer
14%
Endometrium Carcinoma
28%
Enzyme Linked Immunosorbent Assay
14%
Fas Ligand
14%
Inpatient
85%
Malignant Neoplasm
14%
Ovary Carcinoma
42%
Proportional Hazards Model
14%
Radiotherapy
14%
Survival
28%
Survival Rate
14%
Uterine Cervix Cancer
14%
Uterine Cervix Carcinoma
28%
Pharmacology, Toxicology and Pharmaceutical Science
Advanced Cancer
14%
Carcinogenesis
14%
Carcinoma
14%
Death
14%
Endometrium Cancer
14%
Endometrium Carcinoma
28%
Fas Ligand
14%
Malignant Neoplasm
14%
Ovary Carcinoma
42%
Survival
28%
Survival Rate
14%
Uterine Cervix Cancer
14%
Uterine Cervix Carcinoma
28%
Immunology and Microbiology
Alternative RNA Splicing
14%
Apoptosis
28%
Cell Surface
14%
ELISA
14%
Fas Ligand
14%
Natural Killer Cell
14%
Serum Group
14%
Survival
28%
Survival Rate
14%
Biochemistry, Genetics and Molecular Biology
Alternative Splicing
14%
Apoptosis
28%
Carcinogenesis
14%
Fas Ligand
14%
Natural Killer Cell
14%
Serum Group
14%
Survival
28%
Survival Rate
14%